Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.

Effect of epitope variant co-delivery on the depth of CD8 T cell responses induced by HIV-1 conserved mosaic vaccines

Journal article

Wee EG. et al, (2021), Molecular Therapy - Methods & Clinical Development, 21, 741 - 753

Development of Pan-filovirus T cell vaccines against Ebola and Marburg virus challenges

Conference paper

Qiu X. et al, (2019), EUROPEAN JOURNAL OF IMMUNOLOGY, 49, 1664 - 1664

Parallel Induction of CH505 B Cell Ontogeny-Guided Neutralizing Antibodies and tHIVconsvX Conserved Mosaic-Specific T Cells against HIV-1.

Journal article

Wee EG. et al, (2019), Molecular therapy. Methods & clinical development, 14, 148 - 160

MTBVAC-Based TB-HIV Vaccine Is Safe, Elicits HIV-T Cell Responses, and Protects against Mycobacterium tuberculosis in Mice.

Journal article

Broset E. et al, (2019), Molecular Therapy. Methods & Clinical Development, 13, 253 - 264

The impact of vorinostat and therapeutic vaccine on gut HIV DNA: the RIVER gut study

Conference paper

Thornhill J. et al, (2019), HIV MEDICINE, 20, 7 - 7

Efficient Induction of T Cells against Conserved HIV-1 Regions by Mosaic Vaccines Delivered as Self-Amplifying mRNA

Journal article

Moyo N. et al, (2019), Molecular Therapy - Methods & Clinical Development, 12, 32 - 46

Load More